Skip to content
Screener

CeriBell, Inc. CBLL Enterprise value

Enterprise value at other companies

IAR
Integra LifeSciencesIART
$3.15B+20.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$297.01M-7.1%
iRadimed logo
iRadimedIRMD
$617.02M+20.1%
Teladoc Health logo
Teladoc HealthTDOC
$1.79B+134%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$3.73B-20.2%
ICU Medical logo
ICU MedicalICUI
$4.67B+8.0%

Other financials

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation

See full
Market cap$732.29M+54.7%
P/S7.2×+1.1×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

The source filing: CeriBell, Inc.’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 4:50 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342574

FAQ

What is CeriBell, Inc.'s enterprise value?
CeriBell, Inc. (CBLL) reported enterprise value of $727.23M in Q2 2026.
How has CeriBell, Inc.'s enterprise value changed year-over-year?
CeriBell, Inc.'s enterprise value increased by 5.1% year-over-year, from $691.62M to $727.23M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about CeriBell, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude